Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Gabius

Showing results (221-230 of 374) with videos related to

Pageof 38
Sort By:
Pharmaceutical Research|October 12, 2000
Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectinsS André, B Frisch, H Kaltner, et al.
Histology and Histopathology|October 1, 1996
Histochemical detection of expression of binding sites for labelled hyaluronic acid and carrier-immobilized synthetic (histo-blood group trisaccharides) or biochemically purified (ganglioside GM1) glycoligands in nasal polyps and other human lesions including neoplasmsS Hassid, I Salmon, N V Bovin, et al.
Molecular and Cellular Biochemistry|January 26, 1995
Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectinsF Y Zeng, A Benguría, S Kafert, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|January 1, 1995
Will neoadjuvant chemotherapy affect the capacity of head and neck squamous cell carcinoma to bind neoglycoproteins?M K Steuer, M Steuer, V Bonkowsky, et al.
The Clinical Investigator|August 1, 1992
Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patientsJ Beuth, H L Ko, H J Gabius, et al.
Biochemistry. Biokhimiia|June 20, 1998
Formation of lactose-resistant aggregates of human platelets induced by the mistletoe lectin and differential signaling responses to cell contact formation by the lectin or thrombinA B Samal, A V Timoshenko, E N Loiko, et al.
Advanced Drug Delivery Reviews|September 1, 2000
Endogenous lectins as targets for drug deliveryN Yamazaki, S Kojima, N V Bovin, et al.
Glycoconjugate Journal|April 1, 2006
Search for additional influenza virus to cell interactionsE M Rapoport, L V Mochalova, H-J Gabius, et al.
Biochemical and Biophysical Research Communications|May 31, 1990
Carrier-immobilized derivatized lysoganglioside GM1 is a ligand for specific binding sites in various human tumor cell types and peripheral blood lymphocytes and monocytesS Gabius, K Kayser, K P Hellmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1990
Differentiation-related expression of epidermal growth factor receptors in human lung carcinoma demonstrated histochemically by biotinylated epidermal growth factorK Kayser, G Weisse, H J Gabius, et al.
Pageof 38

Showing results (221-230 of 374) with videos related to

Sort By:
Pageof 38
Pharmaceutical Research|October 12, 2000
Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectinsS André, B Frisch, H Kaltner, et al.
Histology and Histopathology|October 1, 1996
Histochemical detection of expression of binding sites for labelled hyaluronic acid and carrier-immobilized synthetic (histo-blood group trisaccharides) or biochemically purified (ganglioside GM1) glycoligands in nasal polyps and other human lesions including neoplasmsS Hassid, I Salmon, N V Bovin, et al.
Molecular and Cellular Biochemistry|January 26, 1995
Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectinsF Y Zeng, A Benguría, S Kafert, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|January 1, 1995
Will neoadjuvant chemotherapy affect the capacity of head and neck squamous cell carcinoma to bind neoglycoproteins?M K Steuer, M Steuer, V Bonkowsky, et al.
The Clinical Investigator|August 1, 1992
Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patientsJ Beuth, H L Ko, H J Gabius, et al.
Biochemistry. Biokhimiia|June 20, 1998
Formation of lactose-resistant aggregates of human platelets induced by the mistletoe lectin and differential signaling responses to cell contact formation by the lectin or thrombinA B Samal, A V Timoshenko, E N Loiko, et al.
Advanced Drug Delivery Reviews|September 1, 2000
Endogenous lectins as targets for drug deliveryN Yamazaki, S Kojima, N V Bovin, et al.
Glycoconjugate Journal|April 1, 2006
Search for additional influenza virus to cell interactionsE M Rapoport, L V Mochalova, H-J Gabius, et al.
Biochemical and Biophysical Research Communications|May 31, 1990
Carrier-immobilized derivatized lysoganglioside GM1 is a ligand for specific binding sites in various human tumor cell types and peripheral blood lymphocytes and monocytesS Gabius, K Kayser, K P Hellmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1990
Differentiation-related expression of epidermal growth factor receptors in human lung carcinoma demonstrated histochemically by biotinylated epidermal growth factorK Kayser, G Weisse, H J Gabius, et al.
Pageof 38